Live Cell Imaging Market, reening), Time-lapse Microscopy, and Others), By Application (Drug Discovery, Cell Biology, Stem Cell, By Product (Software, Instruments, Consumables, and Others), By Technology (FRET (Fluorescence Resonance Energy Transfer), HCS (High Content Scand Others), By End-Users (Research Institutes, Contract Research Organizations, Pharmaceutical Companies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI499322 | Publish Date: February 2024 | No. of Pages: 170

Live Cell Imaging Market Overview

Live Cell Imaging Market was valued at US$ 2.2 Billion in 2024 and is projected to grow at a CAGR of 4.90% to reach US$ 3.4Billion by 2034.

Live Cell Imaging is used for visualizing slow cellular processes which are below threshold of human perception. Live Cell Imaging is currently performed by using fluorescence microscopy and other technology like time lapse microscopy, high content screening are also used. Cell Imaging has become an important analytical tool in study of biomedical research like pharmacology, cell biology, neurobiology, and developmental biology. Imaging of fixed cells & tissues requires high illumination intensity & long exposure time. Various cell culture media are used for imaging media which contains vitamins, amino acids, nucleic acid constituents, lipids, sugars, trace elements, tri-carboxylic acid cycle intermediates, and co-enzymes, etc. Important step in tissue culture media is controlling oxygen concentration, buffering capacity, pH, viscocity, osmolarity, and surface tension. Green fluorescent protein is most commonly used fluorescent protein in imaging cells due to its unique chemical structure, chemically inert and relatively small. Green fluorescent protein is found in natural sources like sea anemones, corals, crustaceans, hydrozoans, and basic chordate animals. Widefield Systems helps in providing flexible system for live cell imaging. Widefield Systems allows fast acquisition, with low cost and flexible excitation. Transmitted light is used with fluorescence microscopy for determining cell position, shape, and motility which are used for investigating mitosis and apoptosis in cell. Phase contrast and differential interference contrast are most commonly used microscopy in cell imaging. In Confocal microscopy Time-lapse imaging of living cells is enhanced by improved resolution. Confocal analysis of live cell has become a good option due to its less phototoxic dyes for labeling and increased efficiency of photons. FRET (Fluorescence Resonance Energy Transfer) helps in increasing spatial resolution of fluorescence to less than 10 nm and also used in monitoring protein to protein interactions inside the living cells.  Fluorescence Quantum Dots are used for live cell imaging due to their enhanced brightness and resistance to metabolic degradation and photo-damage. However, rising prevalence of chronic diseases has enhanced the live cell imaging market growth.

Live Cell Imaging Market Dynamics

Rise in prevalence of chronic diseases and rate of urbanization is one of the leading factors for the Live Cell Imaging Market growth.  Growing number of chronic diseases has driven the target market growth. Urbanization has given rise in consumption of western food, processed food, frozen packed foods, which are unhealthy and affect the health in human being. Urbanization has given rise in disposable income which allows the individual to enhance their lifestyle, consuming high amount of red meat and animal derived food, fats & oils, sugar, sodium, which has affected the digestive health. Eating processed and unhealthy food, lack of exercise affect the health causing chronic disease like heart disease, diabetes, obesity, high blood pressure, gastrointestinal diseases, cancer, etc. Consumption of unhealthy and processed food cause the indigestion, constipation, acidity, bloating of stomach, belching, flatulence, vomiting, feeling uncomfortable, feeling heavy, etc. which has led in rising gastrointestinal diseases. Use of GFP (Green fluorescent protein) in labeling cancer cells in cytoplasm has allowed visualization of nuclear-cytoplasmic dynamics of cancer cells in vivo, cell cycle position, apoptosis, mitosis, and differential behavior of cytoplasm & nucleus occurs during cancer cell deformation. In 2022, according to National Institute of Diabetes and Digestive and Kidney Diseases between 60 million to 70 million Americans are suffering from gastrointestinal disorders which has led to 250,000 deaths each year. For instance, in 2016, (NIH), the relationship between cancer incidence and urbanization in Iran were conducted by using Quantile Regression. Data obtained by Ministry of Health & Medical Education and relationship between urbanization and cancer morbidity was investigated by quantile regression and determined that breast cancers, pancreas, prostate, colorectal and lung cancers increasing with rate of urbanization. 90th percentile was maximum increase rate of breast cancer. 95th percentile was of prostate cancer, 75th percentile was of colorectal cancer, 95th percentile for lung cancer and 10th percentile for pancreas cancer. According to the results, it was determined that there was significant impact of rising urbanization on cancer morbidity due to risk factors like more pollution in urban areas, poor nutrition food, lack of exercise, smoking, alcohol intake, etc. For instance, in 2020, according to (PMC), urban population was 36.6% to 44.8% in 1970-1994 and expected to increase till 61.1% till 2025. Around 70%-80% of colorectal cancer incidence in urban population occurs due to unhealthy lifestyle and environmental factors. According to data published by United Nations in 2018, about 55% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in prevalence of chronic disease and population in urban areas boosts the demand for Live Cell Imaging market.

                                                  Recent technological advancement

Recent technological advancement in live cell imaging has become the major factor in target market growth. Recent advancement in fluorescent reporters and microscopy technology has provided fascinating new insights to dynamic development mechanism. Advancement in computational methods has become the useful and important tool in developing new & improved cell imaging technique. Live cell imaging provides current status of cell or organism. Substantial advancement in optics, fluorescent tag technology and electronics has made live cell imaging easily accessible and more versatile for scientists. Today’s microscopy has offered real time & dynamic perspective of developmental physiology, quantification & correlation of process. Photoactivation is recently developed new technological method used for monitoring gene expression, protein transport, etc. Specially designed dyes like photoactivated-green-fluorescent protein (paGFP) or Kaede is used in photoactivation method for labelling selective areas of interest within organism or cell. These specially designed dyes are fused to protein of interest for studying its expression, transport dynamics by use of FRAP (Fluorescence recovery after photo-bleaching) or particle tracking. FRET (Fluorescence Resonance Energy Transfer) has become useful tool for quantification of protein-DNA interactions, protein-protein interactions, and protein conformational changes. FRAP (Fluorescence recovery after photo-bleaching) is used for monitoring protein & vesicle trafficking. Quantitative imaging of functional changes in cardiovascular functions – new advancement in optical microscopy has provided various ways for imaging the beating heart, and has provided insight into embryonic cardiovascular function. Rapid Confocal Imaging with LSM 5 LIVE has enabled for tracking trajectories of individual blood cells which were moving through circulatory system in mouse embryos & zebrafish. However, recent advancement in live cell imaging technique is expected to give boost growth in target market.

Restrains:

However, damage of cells due to extended exposure of fluorescent light, various technical limitations, addition of dyes and probes to membrane system may interfere with liposomal delivery system properties, incorrect choice of dyes may result in inaccurate data interpretation in fluorescence microscopy. Confocal microscopy is diffraction limited and unable to produce high definition images of oligo-lamellar liposomes and SUVs. However, technical limitations and some disadvantages caused due to incorrect choice of dyes, and extended exposure which cause damage to cells may somewhat restrain the Live Cell Imaging market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Live Cell Imaging Market Segmentation

Live Cell Imaging Market is segmented based on product, technology, application, end-users and region.

Product Insight

On the basis of Product Live Cell Imaging Market is segmented into Software, Instruments, Consumables, and others. Instruments in product insight has dominated the target market growth.

Technology Insights

On the basis of Technology Live Cell Imaging Market is segmented into FRET (Fluorescence Resonance Energy Transfer), HCS (High Content Screening), Time-lapse Microscopy, and others. FRET (Fluorescence Resonance Energy Transfer) in technology insight has dominated the target market growth because it helps in increasing spatial resolution of fluorescence to less than 10 nm and also used in monitoring protein to protein interactions inside the living cells.

Application Insights

On the basis of Application Live Cell Imaging Market is segmented into Drug Discovery, Cell Biology, Stem Cell, and others. Cell Biology has dominated the target market growth because live cell imaging has become important in investigating cells which undergoes change in shapes like apoptosis and mitosis.

End-Users Insight

On the basis of End-Users Live Cell Imaging Market is segmented into Research Institutes, Contract Research Organizations, Pharmaceutical Companies, and others. Research Institutes has dominated the target market growth because live cell imaging provides more information about mechanism of drugs, provides more reliable information which helps in research and development.

Regional Insights:

On region the Live Cell Imaging Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising prevalence of chronic disease, high disposable income, rising awareness among consumers about cancer diseases, rise in drug discovery, research & development, rise in adoption of various cell biology laboratories, is anticipated to increase demand for Live Cell Imaging in the region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Product - Software, Instruments, Consumables, and others

By Technology - FRET (Fluorescence Resonance Energy Transfer), HCS (High Content Screening), Time-lapse Microscopy, and others

By Application - Drug Discovery, Cell Biology, Stem Cell, and others

By End-Users - Research Institutes, Contract Research Organizations, Pharmaceutical Companies, and others

 

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Live Cell Imaging Market report based on product, technology, application, end-users and region:

Live Cell Imaging Market, By Product:

  • Software
  • Instruments
  • Consumables
  • Others

Live Cell Imaging Market, By Technology:

  • FRET (Fluorescence Resonance Energy Transfer)
  • HCS (High Content Screening)
  • Time-lapse Microscopy
  • Others

Live Cell Imaging Market, By Application:

  • Drug Discovery
  • Cell Biology
  • Stem Cell
  • Others

Live Cell Imaging Market, By End-Users:

  • Research Institutes
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Others

Live Cell Imaging Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Live Cell Imaging Market Key Players

The key players operating the Live Cell Imaging Market includes,

  1. Carl Zeiss AG,

Carl Zeiss AG, is founded in 1846, in Jena Germany, which is headquartered in Oberkochem, Germany. Carl Zeiss AG, is the manufacturer of optoelectronics and optical systems. Carl Zeiss AG, offer products like light, ion & electron microscope, binoculars, planetarium projectors, semiconductor lithography equipment, eyeglasses, telescopes, medical devices, spotting scopes, measuring machines, and others.

  1. Danaher Corporation,

Danaher Corporation, is headquartered in Washington D.C., U.S. Danaher Corporation, is the designer, manufacturer, and marketer of commercial products & services, medical & industrial products. It offer solutions on live cell imaging.

  1. Olympus Corporation

Olympus Corporation is founded in 1919 which is headquartered in Shinjuku, Tokyo, Japan. Olympus Corporation is the manufacturer of reprography and optic products. Olympus Corporation offer solutions for live cell imaging. Olympus Corporation offer products like endoscopes & medical devices, cameras, precision machinery & instruments, plastic tableware, etc.

  1. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc., is founded in 1956, which is headquartered in Waltham, Massachusetts, U.S. Thermo Fisher Scientific Inc., is the American supplier of software services, reagents & consumables, and scientific instrumentation. Thermo Fisher Scientific Inc., offer products for research, analysis, discovery, and manufacturing.

  1. CytoSMART Technologies Inc.

CytoSMART Technologies Inc., is the developer and manufacturer of live cell imaging devices for supporting life science researchers by providing optimized solutions to them. CytoSMART Technologies offer systems for live-cell analysis, cell counting by using latest imaging based technology. CytoSMART Technologies offer software modules for quantifying results and time-lapse visualizations.

  1. Nikon Corporation

Nikon Corporation, is founded in 1917, which was headquartered in Minato, Tokyo, Japan. Nikon Corporation is the Japanese multinational company, which is specialized in imaging and optics product. Nikon Corporation offer products like microscopes, binoculars, cameras, measurement instruments, steppers, spotting scopes, rifle scopes, and others.

  1. Merck KgAa

Merck KgAa, is a German multinational company which is headquartered in Darmstadt. Merck KgAa is a leading science & technology company. Merck KgAa offer products in emerging biotechnology, general medicine, diagnostics, neurology & immunology, cosmetics, environmental testing, displays, automotive, architecture products and others.

  1. GE Healthcare

GE Healthcare, is founded in 1994, which is headquartered in Chicago, Illnois, U.S. GE Healthcare is the manufacturer & distributor of radiopharmaceuticals, diagnostic imaging agents, etc. GE Healthcare offer products like ultrasound machines, MRI, bone densitometry, PET, respiratory care systems, patient monitoring systems, and others. GE Healthcare develops, drug discovery, research, information technology, medical diagnostics, and others.

  1. Bio Tek Instruments

Bio Tek Instruments, is founded in 1968, which is headquartered in Winooski, Vermont, U.S. Bio Tek Instruments is a private company. Bio Tek Instruments, is the manufacturer and seller of scientific instruments, software used in research, quality assurance in industries etc. Bio Tek Instruments offer products like microplate readers, imaging & microscopy, etc.

  1. Bio-Rad Laboratories Inc.,

Bio-Rad Laboratories, is founded in 1952, which is headquartered in Hercules, California, U.S. Bio-Rad Laboratories, is the American developer, manufacturer of technological products used for clinical diagnostics, and life science research markets. Bio-Rad Laboratories offer products which includes, software, instruments, reagents, gene expression, areas of cell biology, drug discovery and others.

  1. Keyence Corporation

Keyence Corporation, is founded in 1974, which is headquartered in Osaka, Japan. Keyence Corporation is a developer, manufacturer of vision systems, laser markers, automation sensors, barcode readers, digital microscopes, and measuring instruments. Keyence Corporation offer range of products in various sectors like, semiconductor, electronics, biotechnology, automotive, pharmaceutical, food & packaging, etc.

Live Cell Imaging Market Key Issues Addressed

Recent Development:

  • In May 2022, CytoSMART Technologies has launched the new ‘Omni FL’ which is an advanced fluorescence live-cell imaging analysis system. Newly launched product has allowed scientist to gain greater insight into experiments with reduction of time spent on manual labor and thus has brought research to another level. New ‘Omni FL’ help in continuous capturing whole culture surface for obtaining more complete picture. New ‘Omni FL’ has provided high quality instruments, and powerful software that rapidly advance cell & gene therapy development, and advancement in research.
  • In March 2022, Olympus & Evorion has joined partnership to advance cell therapy research. Combination of Olympus ‘IXplore microscope systems’ & ‘cellSens’ software with Evorion’s ‘CellCity Scout –Al software’ & ‘CellCity System’ make easy and accessible high resolution live cell analysis. This partnership has combined 3D live cell imaging, Al (artificial intelligence) and microfluidics in accessible workflow solution and provide applications in immunology, cancer research and adoptive cell therapy.

Live Cell Imaging Market Company Profile

  • CytoSMART Technologies Inc.*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Carl Zeiss AG
  • Danaher Corporation
  • Olympus Corporation*
  • Thermo Fisher Scientific Inc.
  • Nikon Corporation
  • Merck KgAa
  • GE Healthcare
  • Bio Tek Instruments
  • Bio-Rad Laboratories
  • Keyence Corporation

“*” marked represents similar segmentation in other categories in the respective section

Live Cell Imaging Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End-Users
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Live Cell Imaging  Market, By Product
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Software
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Instruments
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Consumables
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  6. Live Cell Imaging  Market, By Technology, 2022 – 2032, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • FRET (Fluorescence Resonance Energy Transfer)
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • HCS (High Content Screening)
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Time-lapse Microscopy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  7. Live Cell Imaging  Market, By Application, 2022 – 2032, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Drug Discovery
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Cell Biology
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Stem Cell
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  8. Live Cell Imaging  Market, By End-Users, 2022 – 2032, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Research Institutes
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Contract Research Organizations
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Pharmaceutical Companies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  9. Live Cell Imaging  Market, By Region, 2022 – 2032, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  2. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  3. Company Profiles
  • Carl Zeiss AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Olympus Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • CytoSMART Technologies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Nikon Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck KgAa
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio Tek Instruments
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Keyence Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Live Cell Imaging Market is segmented into product, technology, application, end-users and region.

Live Cell Imaging Market is driven by factors like rise in prevalence of chronic diseases, rate of urbanization, and recent technological advancement.

By region, the Live Cell Imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.

The key players operating the Live Cell Imaging Market includes, Carl Zeiss AG, Danaher Corporation, Olympus Corporation, Thermo Fisher Scientific Inc., CytoSMART Technologies Inc., Nikon Corporation, Merck KgAa, GE Healthcare, Bio Tek Instruments, Bio-Rad Laboratories, Keyence Corporation, and others.